RVL PHARMACEUTICALS PLC

Analyst Reco. RVL Pharmaceuticals plc

Equities

RVLPQ

IE00BF2HDL56

Market Closed - OTC Markets Other stock markets 12:55:18 18/06/2024 am IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

12/04	North American Morning Briefing : Big Banks Kick -2-	DJ
21/03	North American Morning Briefing : Investors -2-	DJ

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HC Wainwright Adjusts RVL Pharmaceuticals Price Target to $3 From $4, Maintains Buy Rating	21/23/21	MT
Barclays Adjusts Price Target on RVL Pharmaceuticals to $2 From $3, Keeps Overweight Rating	01/23/01	MT
Barclays Adjusts Price Target on RVL Pharmaceuticals to $3 From $4, Reiterates Overweight Rating	25/22/25	MT
Jefferies Assumes RVL Pharmaceuticals at Hold With $2.50 Price Target	21/22/21	MT
Barclays Reinstates RVL Pharmaceuticals at Overweight With $4 Price Target	05/22/05	MT
HC Wainwright Starts Osmotica Pharmaceuticals at Buy With $5 Price Target	23/21/23	MT
OSMOTICA PHARMACEUTICALS : Cantor Fitzgerald Initiates Osmotica Pharmaceuticals at Overweight Rating With $6 Price Target	24/21/24	MT
OSMOTICA PHARMACEUTICALS : RBC Trims Price Target on Osmotica Pharmaceuticals to $7 From $8, Maintains Outperform Rating, Speculative Risk Qualifier	17/21/17	MT
OSMOTICA PHARMACEUTICALS : RBC Cuts Price Target on Osmotica Pharmaceuticals to $8 From $12, Maintains Outperform-Speculative Risk Rating	17/21/17	MT
OSMOTICA PHARMACEUTICALS : Truist Securities Adjusts Osmotica Pharmaceuticals PT to $8 From $11, Maintains Buy Rating	30/20/30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer